D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
MIRM holding history
Mirum Pharmaceuticals, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MIRM overviewAll 13F holders of MIRMFull Q2 2026 holdings
- Shares (Q2 2026)
- 27,879
- Value
- $3.26M
- % of portfolio
- <0.1%
- Quarters held
- 11
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 27,879 | $3.26M | <0.1% | −139,610−83.4% | Reduced | Holders |
| Q1 2026 | 167,489 | $15.5M | <0.1% | −780,672−82.3% | Reduced | Holders |
| Q4 2025 | 948,161 | $74.9M | 0.1% | +24,652+2.7% | Added | Holders |
| Q3 2025 | 923,509 | $67.7M | 0.1% | +368,552+66.4% | Added | Holders |
| Q2 2025 | 554,957 | $28.2M | <0.1% | +11,680+2.1% | Added | Holders |
| Q1 2025 | 543,277 | $24.5M | <0.1% | +385,925+245.3% | Added | Holders |
| Q4 2024 | 157,352 | $6.51M | <0.1% | +157,352 | New | Holders |
| Q1 2024 | 0 | $0 | 0.0% | −22,178−100.0% | Sold out | Holders |
| Q4 2023 | 22,178 | $654.7K | <0.1% | −1,146−4.9% | Reduced | Holders |
| Q3 2023 | 23,324 | $737.0K | <0.1% | +23,324 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −36,145−100.0% | Sold out | Holders |
| Q3 2022 | 36,145 | $759.0K | <0.1% | +11,309+45.5% | Added | Holders |
| Q2 2022 | 24,836 | $483.0K | <0.1% | +24,836 | New | Holders |